TRANSFORMATION CAPITAL β 2022 Investments
4 investments dated 2022 Β· listed companies and verified rows first Β· show all
Solana Beach, US
Kevin Lustig(Executive Officer, Director)Andrew Martin(Executive Officer, Director)
BoardParker Hinshaw(Director)Paul Stone(Director)
Board seatJared KesselheimΒ· per SEC Form D Β· $6M raise Β· filed Dec 2022
Tebra provides an integrated electronic health record and medical billing platform for independent healthcare practices, including EHR tools, claims management, patient payments, and scheduling capabilities.
Digital HealthEnterprise SoftwareHealthtechSaaSIrvine, US
DANIEL RODRIGUES(Executive Officer, Director)JIM LIM(Director)PERRY WALLACK(Director)MICHAEL MATLY(Director)ROB REID(Director)DAVID COZZENS(Director)
Board seatTodd CozzensΒ· per SEC Form D Β· $25M raise Β· filed Jul 2022
Co-investorsEscalate Capital PartnersOpenView Venture PartnersSilver Lake Partners
.png)
Nayya operates an AI-powered platform that integrates health and financial data from multiple sources to help employees manage their benefits and personal well-being.
AI & Machine LearningEnterprise SoftwareHealthtechHR TechNew York, US
Sina Chehrazi(Founder & CEO)Akash Magoon(Executive Officer, Director)Sina C.(Founder)in
BoardCaroline Xie(Director)Victoria Treyger(Director)in
Co-investorsADP VenturesBow CapitalCameron VenturesEarl Grey CapitalEntrepreneurs Roundtable Accelerator (ERA)Felicis Ventures+9 more
SmarterDx provides a clinical AI platform that helps hospitals and health systems improve documentation, coding, and revenue cycle management by accurately capturing the complexity of patient care.
AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesNew York, US
Michael Gao, MD(CEO and Co-founder)Josh(Co-founder and Chief Product Officer)Joshua Geleris(Executive Officer, Director)Michael Gao(Executive Officer, Director)Parimal(Chief Clinical Officer)
Co-investorsBessemer Venture PartnersEast Post Road VenturesFlare Capital PartnersFloodgateSwitch VenturesVirtue Ventures
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.